|8:00 a.m. ||Registration, Breakfast, and Pharmaceutical Exhibits |
||Chairman's Lecture: Jack Wang, PhD
NGLY1: a novel anti-melanoma target emerging from studying a congenital disorder
|10:15 a.m. ||Break and Pharmaceutical Exhibits |
Interesting Cases from MCW Dermatology
|11:15 a.m.||Nancy B. Esterly, MD Lecture: Peter Lio, MD |
An Integrative Approach to Atopic Dermatitis
|12:15 p.m.||Lunch, Poster Presentations, and WDS Business Meeting |
||Interesting Cases from UW-Madison Dermatology
|1:45 p.m. ||Break and Poster Presentations |
MCW Faculty Lecture: Keely Marshall, MD
|2:30-3:30 p.m. |
Reception and Poster Presentations
|schedule is subject to change|
Peter Lio, MD is a Clinical Assistant Professor of Dermatology & Pediatrics at Northwestern University Feinberg School of Medicine. He received his medical degree from Harvard Medical School, completed his internship in Pediatrics at Boston Children’s Hospital, and his Dermatology training at Harvard, where he served as Chief Resident in Dermatology. While at Harvard, he received formal training in acupuncture.
|Keely Marshall, MD was born in Missoula Montana. Her undergraduate degree was completed at Cal Poly University in San Luis Obispo, where she received a BS in microbiology. Later she pursued her interest in medicine and biomedical research at the Medical College of South Carolina in Charleston South Carolina, where she received her MD and PhD in Immunology. Following medical school, Dr. Marshall completed an internship in Internal Medicine at Loyola University in Maywood Illinois prior to starting her residency in dermatology at the University of Pittsburgh in Pennsylvania. Shortly after residency, she moved to Milwaukee and joined the faculty at the Medical College of Wisconsin.|
|Yu-Chieh (Jack) Wang, PhD received his doctoral degree from The Ohio State University. Prior to joining the Medical College of Wisconsin, Dr. Wang was an Assistant Professor at the University of North Texas Health Science Center. His early research was focused on experimental therapeutics for human cancer and novel small molecules for kinase signaling regulation. He also has worked at the interface of stem cell and cancer biology with an emphasis on posttranslational modification-mediated mechanisms underlying cellular pluripotency and the physio-pathological development of human cells. |
At MCW, Dr. Wang and his group work to provide new insights and resolutions to help overcome challenges in biomedical research and disease treatment. Using human stem cell-based platforms and studying regenerative medicine, they strive to have a better understanding of how these novel approaches can be leveraged to model or treat disease. A focus in the Wang lab is to understand the molecular basis of therapeutic responses in cancer and to develop novel therapeutic strategies through targeting its (de)glycosylation dysregulation. Besides, they have long-standing expertise and interest to study how glycoenzymes are involved in the regulation of cell differentiation and pathogenic development in patients with congenital disorders.
Medical College of Wisconsin Resident Presenters
Brookfield Conference Center
325 S Moorland Rd
Brookfield, WI 53005
Attend in real time via Zoom.
Participate remotely on Friday, October 1st. CME and MOC will be available.
Watch the recording at your convenience.
Video of the meeting will be available through December 31, 2021. CME and MOC will not be available for any delayed viewing. No registration is necessary. We will send the link to all members in early October.
WDS Members: Free
Non-Members: $100, includes 1-year membership
No refunds will be given.
Face coverings are required for all attendees in meetings and events spaces at all times except when eating or speaking from the stage. Both the WDS and the venue are monitoring the recommendations of the CDC. Our full safety protocols are available here. These guidelines will be reviewed frequently and we will inform registrants if there are any changes made.
Dana Kader Robb
activity has been planned and implemented in accordance with the
accreditation requirements and policies of the Accreditation Council for
Continuing Medical Education (ACCME) through the joint providership of Wisconsin Medical Society and the Wisconsin Dermatological Society.
The Wisconsin Medical Society is accredited by the ACCME to provide
continuing medical education for physicians.
AMA Credit Designation Statement
The Wisconsin Medical Society designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience and Scope of Practice
This program is intended for dermatologists, dermatopathologists, dermatologic surgeons, nurse practitioners, physician assistants, WDS members, and other allied healthcare providers who work with patients that have dermatologic diseases. The secondary target audience is dermatology residents.
Statement of Purpose
To keep dermatology providers abreast of relevant new clinical knowledge and dermatological skills, in order to provide quality medical care for their patients, and improved healthcare outcomes.